FDA Drug information
Darifenacin
Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)
- DARIFENACIN DARIFENACIN HYDROBROMIDE 15 mg/1 Alembic Pharmaceuticals Inc.
- DARIFENACIN DARIFENACIN HYDROBROMIDE 15 mg/1 Alembic Pharmaceuticals Limited
- Darifenacin DARIFENACIN HYDROBROMIDE 15 mg/1 Aurobindo Pharma Limited
- Darifenacin DARIFENACIN HYDROBROMIDE 15 mg/1 Macleods Pharmaceuticals Limited
- Darifenacin DARIFENACIN HYDROBROMIDE 15 mg/1 POLYGEN PHARMACEUTICALS INC.
- Darifenacin DARIFENACIN HYDROBROMIDE 15 mg/1 Rising Pharma Holdings, Inc.
- Darifenacin DARIFENACIN HYDROBROMIDE 15 mg/1 Torrent Pharmaceuticals Limited
- DARIFENACIN DARIFENACIN HYDROBROMIDE 7.5 mg/1 Alembic Pharmaceuticals Inc.
- DARIFENACIN DARIFENACIN HYDROBROMIDE 7.5 mg/1 Alembic Pharmaceuticals Limited
- Darifenacin DARIFENACIN HYDROBROMIDE 7.5 mg/1 Aurobindo Pharma Limited
- Darifenacin DARIFENACIN HYDROBROMIDE 7.5 mg/1 Macleods Pharmaceuticals Limited
- Darifenacin DARIFENACIN HYDROBROMIDE 7.5 mg/1 POLYGEN PHARMACEUTICALS INC.
- Darifenacin DARIFENACIN HYDROBROMIDE 7.5 mg/1 Rising Pharma Holdings, Inc.
- Darifenacin DARIFENACIN HYDROBROMIDE 7.5 mg/1 Torrent Pharmaceuticals Limited
Learning Zones
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.